Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s): IPCIF

Healthcare

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its product portfolio includes Oxycodone Hydrochloride ER, Regabatin, Dexmethylphenidate ER, Metformin ER, Venlafaxine ER, Pantoprazole ER, Quetiapine ER, Lamotrigine ER, Levetiracetam ER, Desvenlafaxine ER, Ranolazine ER, and Carvedilol ER. Its product portfolio includes both new products and controlled-release generic products. It also provides analytical services.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc > UP 50%

<< Previous

Bullboard Posts

Next >>

Comment by TankRebel2012on Jun 23, 2020 11:28am

385 Views

Post# 31180958

RE:RE:RE:RE:UP 50%

Red_Deer wrote:

Red_Deer wrote:

TJPatrol1 wrote:

bigkagan wrote: since Mar.23. Only 2 weeks left for FDA to decide. If pot stores are deemed essential why not also allow a safe oipiod like Aximiris to calm nerves in this tense period, hee

GLTA

THUMBs UP eh !!!!!!!!!!!!

Only matter of time to hear what going on inside this company.... Invested a sleeper position because what this company holds is Solid ... one day will wake up in a very big way.

For now we Wait&See $$$$

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle